GENMAB (GE9.SG) (GE9 STU) stock market data APIs
€175.036
-3.69(-2.1%)
as of July 1, 2025
Try our APIs with
free plan!
GENMAB (GE9.SG) Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for GE9.SG.
Prev. Close
175.036
Open
171.3455
High
176.7673
Low
171.3455
52 wk Range
160.5-263.3
Market Cap
22 148 M
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GENMAB (GE9.SG) data using free add-ons & libraries
Get GENMAB (GE9.SG) Fundamental Data
GENMAB (GE9.SG) Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GENMAB (GE9.SG) News
New
Transactions in Connection with Share Buy-back Program
Genmab A/S Company Announcement COPENHAGEN, Denmark; April 22, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to ...
GMAB or RGEN: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Genmab A/S Sponsored ADR (GMAB) and Repligen (RGEN). But which of these two stocks is more attractive to value...
Should Value Investors Buy Genmab (GMAB) Stock?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looki...
Genmab (CPSE:GMAB) Reports US$3 Billion DARZALEX Sales For Q1 2025
Genmab recently reported impressive first-quarter 2025 trade sales for DARZALEX, totaling USD 3,237 million, with strong performance both in the U.S. and internationally. Over the past week, the stock...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
